Real-time enrollment status for this non-alcoholic fatty liver disease clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:45 AM UTC
| NCT Number | NCT07221188 |
| Recruiting Status | Recruiting |
| Condition | Non-alcoholic Fatty Liver Disease |
| Phase | Clinical Trial |
| Target Enrollment | 1,250 participants |
| Active Locations | 43 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 13, 2026: Clinical trial NCT07221188 is currently recruiting participants. This clinical trial study for non-alcoholic fatty liver disease is actively seeking new participants at 43 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07221188 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07221188 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.